ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

SIV INDUSTRIES-Good Performance

Sepracor, to manufacture Pad it axel, an anticancer drug in Canada, with In Nova Pharma being set up for this purpose. Both Dabur and Sepracor's 100 per cent subsidiary, Seprachem will hold 50:50 stake in this company. In Nova would have a paid up capital of $2.5 million. Dabur's contribution to the company's equity will be both in the form of goods as well as cash

Dear reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top